Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05370014 · ClinicalTrials.gov registry record · NA

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

A NA study of Stroke and Diabetes Mellitus, Type 2, sponsored by University of South Carolina.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT05370014 is a NA study of Stroke and Diabetes Mellitus, Type 2 that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 500 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05370014, a NA study of Stroke and Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Interventions

  • BEHAVIORAL Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)

Study Locations (1)

South Carolina

  • University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-01-03
Est. Completion 2026-06-30
Phase NA

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT05370014

The ClinicalTrials.gov registry entry for NCT05370014 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) is the first listed.

NCT05370014 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT05370014 about?

NCT05370014 is a clinical study titled "Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads". This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconom...

What is the current status of trial NCT05370014?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-01-03. Estimated completion is 2026-06-30.

What conditions does trial NCT05370014 study?

This clinical trial studies the following conditions: Stroke, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Chronic Kidney Diseases, Chronic Disease.

What interventions are being tested in trial NCT05370014?

The interventions under investigation include: Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05370014?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05370014 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.